• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down1.17% Nasdaq Down1.19%

    Rigel Pharmaceuticals, Inc. (RIGL)

    -NasdaqGS
    2.88 Down 0.04(1.37%) Apr 28, 4:00PM EDT
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingDec 31, 2015Sep 30, 2015Jun 30, 2015Mar 31, 2015
    Total Revenue 8,537   12,996   5,184   2,178  
    Cost of Revenue -   -   -   -  
    Gross Profit 8,537   12,996   5,184   2,178  
    Operating Expenses
    Research Development16,563  15,501  15,059  15,702  
    Selling General and Administrative4,721  4,276  4,099  4,717  
    Non Recurring -   -   -   -  
    Others -   -   -   -  
    Total Operating Expenses -   -   -   -  
    Operating Income or Loss (12,747) (6,781) (13,974) (18,241)
    Income from Continuing Operations
    Total Other Income/Expenses Net60  109  62  48  
    Earnings Before Interest And Taxes(12,687)(6,672)(13,912)(18,193)
    Interest Expense -   -   -   -  
    Income Before Tax(12,687)(6,672)(13,912)(18,193)
    Income Tax Expense -   -   -   -  
    Minority Interest -   -   -   -  
    Net Income From Continuing Ops(12,687)(6,672)(13,912)(18,193)
    Non-recurring Events
    Discontinued Operations -   -   -   -  
    Extraordinary Items -   -   -   -  
    Effect Of Accounting Changes -   -   -   -  
    Other Items -   -   -   -  
    Net Income (12,687) (6,672) (13,912) (18,193)
    Preferred Stock And Other Adjustments -   -   -   -  
    Net Income Applicable To Common Shares (12,687) (6,672) (13,912) (18,193)

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.